34 results
6-K
EX-99.2
EVGN
Evogene Ltd.
16 Sep 24
Current report (foreign)
4:01pm
to an assessment and understanding of our results of operations, financial condition and prospects for the periods described and as of the date
6-K
EX-99.1
EVGN
Evogene Ltd.
23 May 24
Biomica Presents Positive Clinical Data Update from
11:00am
partial response (PR) upon imaging and RECIST v1.1 assessment and remains actively responding to treatment. Additionally, 64% of patients’ disease stopped … progressing following the combination treatment, and they displayed stable disease (SD) and sustained benefits beyond the first imaging assessment
6-K
EX-10.1
EVGN
Evogene Ltd.
28 Mar 24
Current report (foreign)
4:45pm
or assessment which has been or might be asserted or threatened against it which would have a Material Adverse Effect.
(cc) Title to Real and Personal Property
6-K
EX-99.2
EVGN
Evogene Ltd.
13 Sep 23
Current report (foreign)
7:00am
financial condition and results of operations provides information that we believe to be relevant to an assessment and understanding of our results
6-K
EX-99.1
zsffc39i
23 Aug 23
Current report (foreign)
7:00am
6-K
EX-99.1
3b1uw2evjkaaqifprh
8 Aug 23
Company Presentation August 2023
7:30am
6-K
EX-99.1
x04h8s 36fxbahegbmy
9 May 23
Evogene Ag-Seed Division Awarded Prestigious €1.2M Horizon Grant to
7:00am
6-K
EX-99.1
0eto7c6pr1gj4
15 Sep 22
INVESTOR PRESENTATION Ofer Haviv, President & CEO September 2022
7:02am
6-K
EX-99.2
or0 eh1b4h36
7 Sep 22
Current report (foreign)
7:28am
6-K
EX-99.1
izyup98glt7 awhbxjc
30 Nov 21
Biomica Reports Positive Results from Pre-Clinical Studies in its
7:00am
6-K
EX-99.2
52wml2yk
31 Aug 21
Current report (foreign)
4:43pm
6-K
EX-99.2
3e3wt
23 Jun 21
Current report (foreign)
7:30am
F-3
EX-10.1
8p79eskp8pddhu0zd
19 Feb 21
Shelf registration (foreign)
4:13pm
6-K
EX-10.1
16qd5uv
14 Jan 21
Current report (foreign)
5:02pm
6-K
EX-99.1
jp48aefi5xvsz5
15 Sep 20
Current report (foreign)
4:15pm